Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 1915-1922

  Petráčková, Martina ^a   Staněk, Libor ^a,b   Mandys, Václav ^a   Dundr, Pavel ^b   Vonka, Vladimír ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

bcr abl; Gene modified cells; Granulocyte macrophage colony stimulating factor; Organ damage

Indexed keywords

BCR ABL PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CELL INFILTRATION; CELL LINE; CELL LINEAGE; CELL STRAIN; CYTOKINE PRODUCTION; FEMALE; HEMATOPOIETIC CELL; HYPEREMIA; IMMUNE RESPONSE; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLENOMEGALY; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL LINE, TUMOR; FEMALE; FUSION PROTEINS, BCR-ABL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-2; KIDNEY; LEUKEMIA; LIVER; LUNG; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SPLEEN; T-LYMPHOCYTES, REGULATORY; TUMOR BURDEN;

EID: 84861784900     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1410     Document Type: Article

References (23)

1. Dranoff G, Jaffee E, Lazenby A, et al: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539-3543, 1993. (Pubitemid 23111402)
2. Dranoff G: GM-CSF-based cancer vaccines. Immunol Rev 188: 147-154, 2002.
3. Eager R and Nemunaitis J: GM-CSF gene-transduced tumor vaccines. Mol Ther 12: 18-27, 2005. (Pubitemid 40862352)
4. Gupta R and Emens LA: GM-CSF-secreting vaccines for solid tumors: moving forward. Discov Med 10: 52-60, 2010.
5. Le DT, Pardoll DM and Jaffee EM: Cellular vaccine approaches. Cancer J 16: 304-310, 2010.
6. Gabrilovich DI and Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174, 2009.
7. Youn JI and Gabrilovich DI: The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40: 2969-2975, 2010.
8. Tadmor T, Attias D and Polliack A: Myeloid-derived suppressor cells-their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Br J Haematol 153: 557-567, 2011.
9. Yang L, DeBusk LM, Fukuda K, et al: Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6: 409-421, 2004. (Pubitemid 39361441)
10. Serafini P, Carbley R, Noonan KA, Tan G, Bronte V and Borrello I: High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res 64: 6337-6343, 2004. (Pubitemid 39129439)
11. Pan PY, Ma G, Weber KJ, et al: Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 70: 99-108, 2010.
12. Carrascosa C, Obula RG, Missiaglia E, et al: MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells. Oncogene: Aug 15, 2011 (Epub ahead of print). doi: 10.1038/onc.2011.356.
13. Xing Z, Tremblay GM, Sime PJ and Gauldie J: Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am J Pathol 150: 59-66, 1997. (Pubitemid 27027096)
14. Metcalf D, Mifsud S, Di RL, Robb L, Nicola NA and Alexander W: The biological consequences of excess GM-CSF levels in transgenic mice also lacking high-affinity receptors for GM-CSF. Leukemia 12: 353-362, 1998. (Pubitemid 28138220)
15. Burke B, Pridmore A, Harraghy N, Collick A, Brown J and Mitchell T: Transgenic mice showing inflammation-inducible overexpression of granulocyte macrophage colony-stimulating factor. Clin Diagn Lab Immunol 11: 588-598, 2004. (Pubitemid 38661428)
16. Hirano K, Shimizu Y, Nakayama Y, Minemura M, Yasumura S and Sugiyama T: Overexpression of granulocyte-macrophage colony-stimulating factor in mouse liver enhances the susceptibility of lipopolysaccharide leading to massive apoptosis of hepatocytes. Liver Int 25: 1027-1035, 2005. (Pubitemid 41404026)
17. Petrackova M, Tachezy R and Vonka V: Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin 2 (IL-2) and granulocyte-macrphage colony stimulating factor (GM-CSF): I. Derivation, genetic stability, oncogenicity and immunogenicity. Int J Oncol 40: 1668-1676, 2012.
18. McLaughlin J, Chianese E and Witte ON: In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 84: 6558-6562, 1987.
19. Sobotkova E, Ludvikova V, Petrackova M, et al: Characteristic of two mouse bcr-abl-transformed cell lines: I. General properties of the cells. Folia Biol (Praha) 51: 12-18, 2005. (Pubitemid 40372916)
20. Jelinek F, Sobotkova E and Vonka V: Characteristics of two mouse bcr-abl-transformed cell lines. II. Pathological lesions induced in mice. Folia Biol (Praha) 51: 93-102, 2005. (Pubitemid 41300834)
21. Finke J, Ko J, Rini B, Rayman P, Ireland J and Cohen P: MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. Int Immunopharmacol 11: 856-861, 2011.
22. Vasu C, Dogan RN, Holterman MJ and Prabhakar BS: Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol 170: 5511-5522, 2003. (Pubitemid 36617839)
23. Bhattacharya P, Gopisetty A, Ganesh BB, Sheng JR and Prabhakar BS: GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J Leukoc Biol 89: 235-249, 2011.